Combination of ACE inhibitor with nicorandil provides further protection in chronic kidney disease

American Journal of Physiology - Renal Physiology

Volumn 307, Issue 12, 2014, Pages F1313-F1322

  Shiraishi, Takeshi ^a   Tamura, Yoshifuru ^a   Taniguchi, Kei ^a   Higaki, Masato ^a   Ueda, Shuko ^a   Shima, Tomoko ^a   Nagura, Michito ^a   Nakagawa, Takahiko ^b   Johnson, Richard J ^c   Uchida, Shunya ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Chronic kidney disease; Enalapril; Nicorandil; Oxidative stress; Remnant kidney

Indexed keywords

ENALAPRIL; GLIBENCLAMIDE; NICORANDIL; SIRTUIN 3; SULFONYLUREA RECEPTOR; SUPEROXIDE DISMUTASE; ABCC8 PROTEIN, MOUSE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ANTIOXIDANT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM CHANNEL BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DRUG BINDING SITE; GLOMERULONEPHRITIS; INTERSTITIAL NEPHRITIS; KIDNEY FUNCTION; MALE; NONHUMAN; OXIDATIVE STRESS; PODOCYTE; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; TARGET CELL; ANIMAL; BLOOD PRESSURE; CELL LINE; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECTS; DRUG POTENTIATION; KIDNEY; METABOLISM; MOUSE; NEPHRECTOMY; PATHOLOGY; RENAL INSUFFICIENCY, CHRONIC; SPRAGUE DAWLEY RAT; TIME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; CELL LINE; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENALAPRIL; KATP CHANNELS; KIDNEY; MALE; MICE; NEPHRECTOMY; NICORANDIL; OXIDATIVE STRESS; PODOCYTES; POTASSIUM CHANNEL BLOCKERS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY, CHRONIC; SIRTUIN 3; SULFONYLUREA RECEPTORS; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 84918814022     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00521.2014     Document Type: Article

References (37)

1. Ahmed AK, Kamath NS, El Kossi M, El Nahas AM. The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease. Nephrol Dial Transplant 25: 3977-3982, 2010.
2. Barbato JC. Nicorandil: the drug that keeps on giving. Hypertension 46: 647-648, 2005.
3. Baylis C. Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor. J Clin Invest 94: 1823-1829, 1994.
4. Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol Renal Fluid Electrolyte Physiol 249: F324-F337, 1985.
5. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S. RENAAL Study Investigators: effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861-869, 2001.
6. Brenner BM, Mackenzie HS. Nephron mass as a risk factor for progression of renal disease. Kidney Int Suppl 63: S124-127, 1997.
7. Eguchi Y, Takahari Y, Higashijima N, Ishizuka N, Tamura N, Kawamura Y, Ishida H. Nicorandil attenuates FeCl(3)-induced thrombus formation through the inhibition of reactive oxygen species production. Circ J 73: 554-561, 2009.
8. Freundlich M, Quiroz Y, Zhang Z, Zhang Y, Bravo Y, Weisinger JR, Li YC, Rodriguez-Iturbe B. Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int 74: 1394-402, 2008.
9. Ghosh SS, Krieg R, Massey HD, Sica DA, Fakhry I, Ghosh S, Gehr TW. Curcumin and enalapril ameliorate renal failure by antagonizing inflammation in 5/6 nephrectomized rats: role of phospholipase and cyclooxygenase. Am J Physiol Renal Physiol 302: F439-F454, 2012.
10. Haugen EN, Croatt AJ, Nath KA. Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney Int 58: 144-152, 2000.
11. Horváth I, Donnelly LE, Kiss A, Paredi P, Kharitonov SA, Barnes PJ. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress. Thorax 53: 668-672, 1998.
12. Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, Jiang JP, Liang M, Wang GB, Liu ZR, Geng RW. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 354: 131-140, 2006.
13. Ishii H, Ichimiya S, Kanashiro M, Amano T, Imai K, Murohara T, Matsubara T. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation 112: 1284-1288, 2005.
14. Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kuzuya T, Hori M, Higashino Y, Fujii K, Minamino T. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 33: 654-660, 1999.
15. Iwakura K, Ito H, Okamura A, Koyama Y, Date M, Higuchi Y, Inoue K, Kimura R, Nagai H, Imai M, Toyoshima Y, Ozawa M, Ito N, Okazaki Y, Shibuya M, Suenaga H, Kubota A, Fujii K. Nicorandil treatment in patients with acute myocardial infarction: a meta-analysis. Circ J 73: 925-931, 2009.
16. Kanazawa M, Kawamura T, Li L, Sasaki Y, Matsumoto K, Kataoka H, Ito O, Minami N, Sato T, Ootaka T, Kohzuki M. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation. Am J Hypertens 19: 80-86, 2006.
17. Konno Y, Kimura K. Vasodilatory effect of cilnidipine, an L-type and N-type calcium channel blocker, on rat kidney glomerular arterioles. Int Heart J 49: 723-732, 2008.
18. Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsärinne K, Oto A, Parkhomenko A, Piegas LS, Svendsen TL, Teo KK, Yusuf S. ONTARGET investigators: renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372: 547-553, 2008.
19. Matsuda H, Hayashi K, Wakino S, Kubota E, Honda M, Tokuyama H, Takamatsu I, Tatematsu S, Saruta T. Role of endothelium-derived hyperpolarizing factor in ACE inhibitor-induced renal vasodilation in vivo. Hypertension 43: 603-609, 2004.
20. Mehdi UF, Adams-Huet B, Raskin P, Vega GL, Toto RD. Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy. J Am Soc Nephrol 20: 2641-2650, 2009.
21. Mundel P, Reiser J, Zúñiga Mejía Borja A, Pavenstädt H, Davidson GR, Kriz W, Zeller R. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248-258, 1997.
22. O’Rourke B. Evidence for mitochondrial K_ channels and their role in cardioprotection. Circ Res 94: 420-432, 2004.
23. Ozden O, Park SH, Kim HS, Jiang H, Coleman MC, Spitz DR, Gius D. Acetylation of MnSOD directs enzymatic activity responding to cellular nutrient status or oxidative stress. Aging (Albany NY) 3: 102-107, 2011.
24. Reslerova M, Loutzenhiser R. Divergent mechanisms of ATP-sensitive K_ channel-induced vasodilation in renal afferent and efferent arterioles. Evidence of L-type Ca2_ channel-dependent and-independent actions of pinacidil. Circ Res 77: 1114-1120, 1995.
25. Ruggenenti P, Perna A, Remuzzi G; Gruppo Italiano di Studi Epidemiologici in Nefrologia. ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril efficacy in nephropathy. J Am Soc Nephrol 12: 2832-2837, 2001.
26. Sato T, Sasaki N, O’Rourke B, Marbán E. Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol 35: 514-518, 2000.
27. Serizawa K, Yogo K, Tashiro Y, Koike N, Aizawa K, Hirata M, Ishizuka N. Nicorandil ameliorated hypertensive renal injury without lowering blood pressure in spontaneously hypertensive rats. Pharmacology 91: 92-103, 2013.
28. Shimizu S, Saito M, Kinoshita Y, Ohmasa F, Dimitriadis F, Shomori K, Hayashi A, Satoh K. Nicorandil ameliorates ischaemia-reperfusion injury in the rat kidney. Br J Pharmacol 163: 272-282, 2011.
29. Sudo H, Hirata M, Kanada H, Yorozu K, Tashiro Y, Serizawa K, Yogo K, Kataoka M, Moriguchi Y, Ishizuka N. Nicorandil improves glomerular injury in rats with mesangioproliferative glomerulonephritis via inhibition of proproliferative and profibrotic growth factors. J Pharm Sci 111: 53-59, 2009.
30. Tamura Y, Tanabe K, Kitagawa W, Uchida S, Schreiner GF, Johnson RJ, Nakagawa T. Nicorandil, a KATP channel opener, alleviates chronic renal injury by targeting podocytes and macrophages. Am J Physiol Renal Physiol 303: F339-F349, 2012.
31. Tanabe K, Lanaspa MA, Kitagawa W, Rivard CJ, Miyazaki M, Klawitter J, Schreiner GF, Saleem MA, Mathieson PW, Makino H, Johnson RJ, Nakagawa T. Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse. Am J Physiol Renal Physiol 302: F1151-F1160, 2012.
32. Tao R, Coleman MC, Pennington JD, Ozden O, Park SH, Jiang H, Kim HS, Flynn CR, Hill S, Hayes McDonald W, Olivier AK, Spitz DR, Gius D. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol Cell 40: 893-904, 2010.
33. Vilayur E, Harris DC. Emerging therapies for chronic kidney disease: what is their role? Nat Rev Nephrol 5: 375-383, 2009.
34. Yamada M, Isomoto S, Matsumoto S, Kondo C, Shindo T, Horio Y, Kurachi Y. Sulphonylurea receptor 2B and Kir6.1 form a sulphonylureasensitive but ATP-insensitive K_ channel. J Physiol 499: 715-720, 1997.
35. Yung LM, Wong WT, Tian XY, Leung FP, Yung LH, Chen ZY, Yao X, Lau CW, Huang Y. Inhibition of renin-angiotensin system reverses endothelial dysfunction and oxidative stress in estrogen deficient rats. PLoS One 6: e17437, 2011.
36. Zhang AH, Tam P, LeBlanc D, Zhong H, Chan CT, Bargman JM, Oreopoulos DG. Natural history of CKD stage 4 and 5 patients following referral to renal management clinic. Int Urol Nephrol 41: 977-982, 2009.
37. Zhang YJ, Zhang AQ, Zhao XX, Tian ZL, Yao L. Nicorandil protects against ischaemia-reperfusion injury in newborn rat kidney. Pharmacology 92: 245-256, 2013.